NewsFlash: Band-Aid Sized Encapsulation Device Goes to FDA!
VC-01™ Combination Product – Improving Diabetes Treatment
ViaCyte has integrated two of its novel technologies, PEC-01™ cells and the Encaptra® drug delivery system, into one therapy called VC-01™ combination product.
The goal is to begin testing in patients with type 1 diabetes within the next two years.
The goal is to begin testing in patients with type 1 diabetes within the next two years.
Sem comentários:
Enviar um comentário